Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 100.47
-9.53 (-8.66%)
At close: Aug 21, 2026
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 13.22 billion as of August 21, 2026. Its market cap has increased by 61.84% in one year.
Market Cap
13.22B
Enterprise Value
12.94B
Revenue
1.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
100.47
ChartMarket Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 13.22B, an increase of 200.24%. That is a compound annual growth rate of 17.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 13.22B | 78.14% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 17.58B |
| BrightGene Bio-Medical Technology | 16.32B |
| Sino Biological,Inc. | 16.00B |
| HitGen | 15.51B |
| GemPharmatech | 14.72B |
| Acrobiosystems | 14.34B |
| Jinyu Bio-technology | 14.31B |
| Anhui Anke Biotechnology (Group) | 14.10B |